- Intense competition for qualified employees; managing environmental footprint as the business grows; ensuring equitable access to clinical trials and treatments for all patients.
Sarepta Therapeutics, Inc.
Greenhouse gas emissions & sustainability report data
In its 2023 reporting, Sarepta Therapeutics, Inc. disclosed greenhouse gas emissions of 7.2K tCO2e (2023). By scope: Scope 1: 4.8K tCO2e (2023); Scope 2: 2.4K tCO2e (2023). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
7.2K tCO2e (2023)
2023
Water Usage
3.0M gallons (2023)
2023
Waste
149 metric tons (2022), 135 metric tons (2023)
2023
📊 Emissions by Scope (2023)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 4.8K tCO2e (2023) |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 2.4K tCO2e (2023) |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- Implemented nighttime and weekend setback programs for lighting and heating; undertook a companywide re-lamping initiative to replace bulbs with LEDs; implemented recycling programs; employed single-stream recycling at Andover, MA site; established a sustainability committee in Ohio labs.
- Overall waste diversion rate of 31% in 2022 and 19% in 2023.
🌱 ESG Focus Areas
Research and Development InnovationProduct Safety and QualityEthical Marketing PracticesEnvironmental ImpactData Privacy and SecurityEmployee Health and SafetyInclusion, Belonging, and ConnectionCorporate Governance and Compliance